Jerry Markar
Anesthesiology · Los Angeles, CANPI 1083145320
Payments from drug & device makers
Across 50 payments — averaging $91.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$3K
- Nalu Medical, Inc.$374
- Painteq LLC$257
- Nevro Corp.$159
- Medtronic$100
- Johnson & Johnson$69
- plus $278 from 9 others
What the payments were for
- Travel & lodging$1,61335%
- Food & beverage$2,94164%
- Education$150%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 25 | $3,333 |
| Nalu Medical, Inc. | 4 | $374 |
| Painteq LLC | 2 | $257 |
| Nevro Corp. | 1 | $159 |
| Medtronic | 3 | $100 |
| Johnson & Johnson | 3 | $69 |
| Ardelyx, Inc. | 2 | $46 |
| Vertos Medical, Inc. | 2 | $46 |
| Relievant Medsystems, Inc. | 1 | $34 |
| Avanos Medical | 2 | $32 |
| GRT US Holding, Inc. | 1 | $31 |
| SPR Therapeutics, Inc | 1 | $26 |
| Tersera Therapeutics LLC | 1 | $25 |
| Madrigal Pharmaceuticals | 1 | $24 |
| Celltrion USA Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,569 in reported general payments places this provider in the 95th percentile of 5,717 anesthesiology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 27 | $3,890 |
| Pregabalin | 154 | $3,294 |
| Gabapentin | 238 | $2,426 |
| Lidocaine | 19 | $2,296 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 99 | $2,029 |
| Duloxetine Hcl | 38 | $1,071 |
| Naloxone Hcl | 15 | $869 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 51 | $606 |
| Buprenorphine Hcl | 47 | $407 |
| Diclofenac Sodium | 15 | $399 |
| Tizanidine Hcl | 34 | $394 |
| Methocarbamol | 52 | $375 |
| Tramadol Hcl | 46 | $302 |
| Oxycodone Hcl | 20 | $144 |
| Morphine Sulfate | 11 | $68 |
Paid to pharmacies, not to this prescriber.
Other anesthesiology in Los Angeles
- Eilon GabelLos Angeles$1.2M
- Maxime CannessonLos Angeles$759K
- Moody MakarLos Angeles$252K
- Jonathan JahrLos Angeles$223K
- Anahat DhillonLos Angeles$184K
- Michael BottrosLos Angeles$182K
- David BoldtLos Angeles$153K
- Kamal MaheshwariSacramento$1.9M
- Gregory HammerStanford$1.8M
- Neal FlemingSacramento$1.7M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.